Oncobesity News Posts

How Ozempic and Wegovy are quietly cutting America’s food bills

Weight-loss drugs like Ozempic and Wegovy are changing how Americans spend money on food. A large Cornell study found households cut grocery spending by over 5% within six months, with even bigger drops at fast-food restaurants. Snack foods and sweets saw the steepest declines, while only a few categories like yogurt and fruit rose slightly. The effects linger for at least a year among continued users.

Read More »

Novo Nordisk’s (NVO)

Novo Nordisk’s (NVO) Novo Nordisk A/S Sponsored ADR Class B BATS:NVO KalaGhazi Based on a detailed technical analysis of Novo Nordisk’s (NVO) stock in the

Read More »

Drug approvals to watch in 2026

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with

Read More »